셀마크한국

비상장계속사업자

CELLMARK KOREA

안형준, 호앙탄응우웬

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

셀마크한국

Business Reg. No. 4638801004 · CEO 안형준, 호앙탄응우웬

I.Investment Overview

Target셀마크한국 (4638801004)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명셀마크한국
영문명CELLMARK KOREA
대표자안형준, 호앙탄응우웬
사업자등록번호4638801004
법인등록번호1101116648054
설립일2018.03.02

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW696.82020990.220211,484.52022840.22023298.52024
영업이익100M KRW0.72020-0.620212.720223.620234.72024
순이익100M KRW0.320201202132022-23.320232.32024
Item20242023202220212020
자산총계40.2억원133.8억원476.6억원296.8억원113.9억원
부채총계27.3억원149.8억원469.3억원292.4억원110.5억원
자본총계12.9억원-16억원7.4억원4.4억원3.4억원
매출액298.5억원840.2억원1,484.5억원990.2억원696.8억원
영업이익4.7억원3.6억원2.7억원-5,855만원7,051만원
순이익2.3억원-23.3억원3억원9,541만원2,622만원

VI.Financial Ratios

FY2024 basis

1.56%

영업이익률

0.76%

순이익률

5.65%

ROA

17.59%

ROE

211.52%

부채비율

32.1%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

셀마크한국 투심보고서 | Alpha Lenz